Predicting [ 90 Y]Y-FAPI-46 Tumor Absorbed Dose from Single-Time-Point [ 68 Ga]Ga-FAPI-46 PET/CT Imaging
Journal of Nuclear Medicine · 29.10.2026 · jnumed.126.273258
DOI: 10.2967/jnumed.126.273258 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 29.10.2026. Verfasst von Masao Watanabe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; and. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Radiolabeled fibroblast activation protein (FAP)-targeting peptides, such as 90Y-FAPI-46, have increasingly been used to treat various tumor entities, with preliminary reports indicating therapeutic responses with acceptable toxicity profiles. Dosimetry can be used to maximize antitumor capability and minimize side effects. The aim of this study was to investigate whether 90Y-FAPI-46 tumor dosimetry can be predicted by diagnostic 68Ga-FAPI-46 PET/CT data.
Methods
Fourteen patients with 24 lesions underwent a single-time-point 68Ga-FAPI-46 PET/CT scan and 3 90Y-FAPI-46 PET/CT scans for dosimetry within a 3-mo interval. Tumors were identified on PET images, and the anatomic tumor volume was measured on low-dose CT. Tumor uptake extrapolated at time of injection, time-integrated activity coefficient (TIAC), and tumor absorbed dose were calculated as reference values using 90Y-FAPI-46 data and compared with the corresponding predicted values using 68Ga-FAPI-46 data by means of a single-time-point dosimetry model. Correlations between 90Y-FAPI-46- and 68Ga-FAPI-46-based values were assessed.
Results
In calculating the predicted values using a single-time-point 68Ga-FAPI-46 PET/CT, the mean effective half-life of 90Y-FAPI-46 across all lesions was 8.44 ± 1.73 h. The mean ± SD ratio (i.e., the predicted values using 68Ga-FAPI-46 data divided by the reference 90Y-FAPI-46 data) were 0.93 ± 0.39, 0.77 ± 0.35, and 0.77 ± 0.35 for tumor uptake, TIAC, and tumor absorbed dose, respectively. In the Bland-Altman analysis, mean differences (bias) ± SD of the percent differences of tumor uptake, TIAC, and tumor absorbed dose were -16.11% ± 43.28% (95% CI, -100.90 to 68.73%; Spearman ρ = 0.91; P < 0.0001), -32.60% ± 41.26% (95% CI, -113.50 to 48.26%; Spearman ρ = 0.91; P < 0.0001), and -33.35% ± 40.19% (95% CI, -112.10 to 45.43%; Spearman ρ = 0.77; P < 0.0001), respectively.
Conclusion
Tumor uptake, TIAC, and tumor absorbed dose on 90Y-FAPI-46 PET/CT and 68Ga-FAPI-46 PET/CT were highly correlated, although the values on 68Ga-FAPI-46 PET/CT tended to be lower than those on 90Y-FAPI-46 PET/CT. Predicted values on 68Ga-FAPI-46 PET/CT can help clinicians with diagnostic stratification and patient selection, with intratherapeutic verification remaining necessary before any individualization of administered activity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; and.
- German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.
- Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; and walter.jentzen@uk-essen.de.
Zitieren
APA
Watanabe, M., Jentzen, W., Herrmann, K., Kersting, D., & Fragoso Costa, P. (2026). Predicting [ 90 Y]Y-FAPI-46 Tumor Absorbed Dose from Single-Time-Point [ 68 Ga]Ga-FAPI-46 PET/CT Imaging. Journal of Nuclear Medicine, jnumed.126.273258. https://doi.org/10.2967/jnumed.126.273258
Vancouver
Watanabe M, Jentzen W, Herrmann K, Kersting D, Fragoso Costa P. Predicting [ 90 Y]Y-FAPI-46 Tumor Absorbed Dose from Single-Time-Point [ 68 Ga]Ga-FAPI-46 PET/CT Imaging. Journal of Nuclear Medicine. 2026:jnumed.126.273258. doi:10.2967/jnumed.126.273258
BibTeX
@article{Watanabe2026,
author = {Watanabe, Masao and Jentzen, Walter and Herrmann, Ken and Kersting, David and Fragoso Costa, Pedro},
title = {Predicting [ 90 Y]Y-FAPI-46 Tumor Absorbed Dose from Single-Time-Point [ 68 Ga]Ga-FAPI-46 PET/CT Imaging},
journal = {Journal of Nuclear Medicine},
year = {2026},
pages = {jnumed.126.273258},
doi = {10.2967/jnumed.126.273258}
}
EUVIMED